Son[VEER]
Upgrade · Coming SoonBIOCON
NSE: BIOCON
₹390.65
Healthcare · Nifty 500 · as of 11SEP2026
Long-Term Read
• Neutral / No Clear Read · 0.49
Score
49/100
This is a percentile rank of this stock against the rest of the Nifty 500 today, not a probability or return forecast.
Long-Term Drivers
TechLong-Term Momentum
200-session price momentum.
-0.0114
as of 11SEP2026
+5 pts to score
TechSector Tailwind
Sector relative strength vs. the broader market.
0.0003
as of 11SEP2026
0 pts to score
What changed, and when
10SEP2026
• Flipped to Neutral / No Clear Read
Driven by: Long-Term Momentum, Sector Momentum (Extended)
09SEP2026
↓ Flipped to Veering Down
Driven by: Sector Tailwind, Long-Term Momentum
28AUG2026
• Flipped to Neutral / No Clear Read
Driven by: Long-Term Momentum, Sector Momentum (Extended)
25AUG2026
↑ Flipped to Veering Up
Driven by: Long-Term Momentum, Sector Momentum (Extended)
24AUG2026
• Flipped to Neutral / No Clear Read
Driven by: Long-Term Momentum, Sector Momentum (Extended)
27JUL2026
↑ Flipped to Veering Up
Driven by: Long-Term Momentum, Sector Momentum (Extended)
24JUL2026
↑ Flipped to Strongly Veering Up
Driven by: Long-Term Momentum, Sector Tailwind
17JUL2026
↑ Veering Up · first read on record
Sector Peers · Healthcare
Past Prints
Track record begins at launch. Check back soon.